Saturday, January 4, 2014

Johnson & Johnson Risperdal Linked to Male Breast Development | CCHR International

Johnson & Johnson Risperdal Linked to Male Breast Development | CCHR International

J&J has come under media scrutiny once again for side effects associated with the antipsychotic drug Risperdal. The drug has been linked to causing Gynecomastia in males.
Digital Journal – January 3, 2014
By Greg Jones Law
Johnson & Johnson, the pharmaceutical giant known worldwide as a maker of a variety of popular pharmaceutical products, has come under media scrutiny once again for manufacturing potential defective drugs. This time, however, the scrutiny surrounds the side effects associated with the manufacturing of a particular antipsychotic known as Risperdal. Specifically, the drug has been linked to causing Gynecomastia in males.
Prescription Risperdal
Risperdal is a drug prescribed for the treatment of mental disorders like bipolar, schizophrenia and autism.

No comments: